Effects of Cerebrolysin on neuropsychiatric symptoms in Alzheimer's disease: results of a randomized, placebo-controlled trial

被引:0
|
作者
Alvarez, A. [1 ]
Cacabelos, R. [1 ]
Couceiro, V. [1 ]
Aleixandre, M. [2 ]
Doppler, E. [3 ]
Novak, P. [3 ]
Moessler, H. [3 ]
机构
[1] EuroEspes Biomed Res Ctr, La Coruna, Spain
[2] Univ Granada, Sch Psychol, Granada, Spain
[3] EVER Neuro Pharma GmbH, Unterach, Austria
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:72 / 72
页数:1
相关论文
共 50 条
  • [41] A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease
    Sano, M.
    Bell, K. L.
    Galasko, D.
    Galvin, J. E.
    Thomas, R. G.
    van Dyck, C. H.
    Aisen, P. S.
    NEUROLOGY, 2011, 77 (06) : 556 - 563
  • [42] Efficacy of donepezil in early-stage Alzheimer disease - A randomized placebo-controlled trial
    Seltzer, B
    Zolnouni, P
    Nunez, M
    Goldman, R
    Kumar, D
    Ieni, J
    Richardson, S
    ARCHIVES OF NEUROLOGY, 2004, 61 (12) : 1852 - 1856
  • [43] Correction: Masitinib for mild-to-moderate Alzheimer’s disease: results from a randomized, placebo-controlled, phase 3, clinical trial
    Bruno Dubois
    Jesús López‑Arrieta
    Stanley Lipschitz
    Triantafyllos Doskas
    Luiza Spiru
    Svitlana Moroz
    Olena Venger
    Patrick Vermersch
    Alain Moussy
    Colin D. Mansfield
    Olivier Hermine
    Magda Tsolaki
    Alzheimer's Research & Therapy, 15
  • [44] The efficacy and safety of donepezil in patients with Alzheimer's disease: Results of a US multicentre, randomized, double-blind, placebo-controlled trial
    Rogers, SL
    Friedhoff, LT
    Apter, JT
    Richter, RW
    Hartford, JT
    Walshe, TM
    Baumel, B
    Linden, RD
    Kinney, FC
    Doody, RS
    Borison, RL
    Ahem, GL
    DEMENTIA, 1996, 7 (06): : 293 - 303
  • [45] Sembragiline in Moderate Alzheimer's Disease: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Trial (MAyflOwer RoAD)
    Nave, Stephane
    Doody, Rachelle S.
    Boada, Merce
    Grimmer, Timo
    Savola, Juha-Matti
    Delmar, Paul
    Pauly-Evers, Meike
    Nikolcheva, Tania
    Czech, Christian
    Borroni, Edilio
    Ricci, Benedicte
    Dukart, Juergen
    Mannino, Marie
    Carey, Tracie
    Moran, Emma
    Gilaberte, Inma
    Muelhardt, Nicoletta Milani
    Gerlach, Irene
    Santarelli, Luca
    Ostrowitzki, Susanne
    Fontoura, Paulo
    JOURNAL OF ALZHEIMERS DISEASE, 2017, 58 (04) : 1217 - 1228
  • [46] A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease
    Singer, C
    Tractenberg, RE
    Kaye, J
    Schafer, K
    Gamst, A
    Grundman, M
    Thomas, R
    Thal, LJ
    SLEEP, 2003, 26 (07) : 893 - 901
  • [47] Effects of ETyrosine on Parkinson's Disease: A Randomized, Double-Blind, Placebo-Controlled Trial
    DiFrancisco-Donoghue, Joanne
    Rabin, Ely
    Lamberg, Eric M.
    Werner, William G.
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2014, 1 (04): : 348 - 353
  • [48] GINKGO BILOBA EXTRACT EGB 761 IN MILD COGNITIVE IMPAIRMENT WITH NEUROPSYCHIATRIC SYMPTOMS: A RANDOMIZED PLACEBO-CONTROLLED TRIAL
    Preuss, U. W.
    Bachinskaya, N.
    Kaschel, R.
    Wong, J. W.
    Hoerr, R.
    Gavrilova, S. I.
    EUROPEAN PSYCHIATRY, 2013, 28
  • [49] Effects of simvastatin in chronic obstructive pulmonary disease: Results of a pilot, randomized, placebo-controlled clinical trial
    Balaguer, Catalina
    Peralta, Alejandro
    Rios, Angel
    Iglesias, Amanda
    Lluis Valera, Josep
    Noguera, Aina
    Soriano, Joan B.
    Agusti, Alvar
    Sala-Llinas, Ernest
    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2016, 2 : 91 - 96
  • [50] Rotigotine transdermal patch for the treatment of neuropsychiatric symptoms in Parkinson's disease: A meta-analysis of randomized placebo-controlled trials
    Wang, Hao-tian
    Wang, Li
    He, Yi
    Yu, Gang
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2018, 393 : 31 - 38